Actively Recruiting
Remote Temperature Monitoring of Patients At Risk for Developing Fever
Led by AION Biosystems · Updated on 2024-12-30
150
Participants Needed
1
Research Sites
73 weeks
Total Duration
On this page
Sponsors
A
AION Biosystems
Lead Sponsor
E
Ellis Medicine
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this program is to evaluate remote temperature monitoring in cancer patients at risk of fever and infection due to chemotherapy treatment. The main questions it aims to answer are: * does remote temperature monitoring reduce the number of days spent inpatient * what out-of-pocket cost can a patient expect to incur for participating in remote temperature monitoring * the number of billable CPT codes that will be generated by providing remote temperature monitoring Researchers will compare compliant and non-compliant patients to assess if compliance with remote temperature monitoring is associated with a decrease in the number of days spent inpatient. Patients will * wear the thermometer for the duration of their participation in the study * have their temperature monitored continuously * receive alerts on their phone when their temperature exceeds a threshold for a sustained duration, configurable by their physician * respond to texts or calls from remote monitors when an alert is triggered
CONDITIONS
Official Title
Remote Temperature Monitoring of Patients At Risk for Developing Fever
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Subject is at risk of a fever post discharge.
- Subject is 65 18 years or older.
- Subject has an iOS or Android phone, or is able to operate an AION provided smartphone device.
- Subject is willing to install the TempShield app on his/her phone.
- Subject is willing to allow AION to send text reminders to take temperature or complete surveys.
- Subject is willing to take an oral temperature as directed by their care plan.
- Subject is willing to configure the phone to ensure these notifications are delivered, even when phone is in a "no notification" mode.
- Subject or subject caretaker is able and willing to complete subject surveys.
- Subject is willing and able to provide written informed consent in English.
- Subject is willing and able to comply with all program procedures, requirements, assessments, visits, and complete questionnaires.
- English speakers
You will not qualify if you...
- Unable to provide informed consent
- Subjects with a history of Medical Adhesive-Related Skin Injury (MARSI)
- Subjects with no available placement that avoids open wounds or traumatized skin (burns. Blisters. Etc.)
- Non-English speakers: The mobile application is only currently available in English. Future development will include other languages.
- Subjects receiving prophylactics that could induce fever.
- Subjects with a silicon allergy
- Subject does not have iOS or Android phone, and is unable to operate an AION provided smartphone device.
- Subjects who are not willing to take an oral temperature per their care plan.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ellis Hospital
Schenectady, New York, United States, 12308
Actively Recruiting
Research Team
D
David Colburn, Ph.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here